Skip to main content

MARSHALL WACE, LLP

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,159,830
+$5,533,778 QoQ
Shares Held
448,118
+26.7% QoQ
Ownership
0.753%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. AGIO ranks #41 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,159,830 448,118
2025-12-31 $9,626,052 353,639
2025-09-30 $9,104,715 226,824
2025-06-30 $22,772,090 684,669
2025-03-31 $15,261,578 520,873
2024-12-31 $20,755,295 631,628
2024-09-30 $56,127,752 1,263,285
2024-06-30 $48,886,653 1,133,735
2024-03-31 $8,128,603 277,996
2023-09-30 $1,436,490 58,040
2022-09-30 $407,599 14,413
2022-06-30 $965,791 43,563
2021-12-31 $479,277 14,581
2020-12-31 $1,901,233 43,878
2020-09-30 $1,385,755 39,593
2020-03-31 $1,959,702 55,234